- Home
- XTNT vs PHUN Comparison
XTNT vs PHUN Comparison
Compare XTNT & PHUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XTNT | PHUN |
|---|---|---|
| Founded | N/A | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.9M | 40.1M |
| IPO Year | 2009 | 2016 |
Fundamental Metrics
Financial Performance| Metric | XTNT | PHUN |
|---|---|---|
| Price | $0.32 | $2.10 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $1.03 | N/A |
| AVG Volume (30 Days) | ★ 185.7K | 78.4K |
| Earning Date | 11-09-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 125.00 | 39.36 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $53,337,000.00 | $30,883,000.00 |
| Revenue This Year | N/A | $37.21 |
| Revenue Next Year | $10.85 | $1,931.97 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 15.57 |
| 52 Week Low | $0.27 | $1.56 |
| 52 Week High | $0.95 | $3.04 |
Technical Indicators
Market Signals| Indicator | XTNT | PHUN |
|---|---|---|
| Relative Strength Index (RSI) | 39.89 | 63.54 |
| Support Level | $0.32 | $2.03 |
| Resistance Level | $0.49 | $2.27 |
| Average True Range (ATR) | 0.02 | 0.05 |
| MACD | -0.00 | 0.02 |
| Stochastic Oscillator | 0.00 | 94.74 |
Price Performance
Historical ComparisonAbout XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.
About PHUN Phunware Inc.
Phunware Inc is a software company. It is a cloud platform for mobile that provides companies with the products, solutions, and data and services necessary to engage, manage and monetize its mobile application audiences. It derives maximum revenue from United States. The company has two reportable segments: Software subscriptions and services; and Advertising. It derives maximum revenue from Software subscriptions and services. Development services for customers who wish to have a customized application experience; and In-app advertising services for mobile audience building, user acquisition, application discovery, audience engagement and monetization.